PLAY PODCASTS
Whom to Screen for Hepatitis Delta Virus
Episode 231

Whom to Screen for Hepatitis Delta Virus

Listen as 2 experts discuss the impact of hepatitis delta virus infection on liver disease progression and the potential burden of going undiagnosed.

Decera Clinical Education Infectious Disease Podcast · Nancy Reau MD, Coleman I Smith MD

December 15, 202213m 28s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be tested, including:

  • Epidemiology of HDV infection
  • Clinical course of HDV infection
  • Populations at high risk of HDV infection
  • Guidelines for HDV testing

Faculty: 
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology 
Associate Director, Solid Organ Transplantation 
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Coleman I. Smith, MD
Professor of Medicine
Hepatologist
Georgetown Transplant Institute
Georgetown University
Washington, DC

Link to full program: 
https://bit.ly/3WmJnzi

Follow along with the slides at:
https://bit.ly/3NpAYI1


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

cirrhosiscommercial sex workershepatitis delta infectionprevalencemigrants from endemic countriesmsmaasldhepatocellular carcinomaindividuals who inject drugshdvsuperinfectioncoinfectionhepatitis b infectionliver cancerhepatitis cfibrosishbvguidelineshcchepatitis b surface antigenliver transplantationhivdialysis